España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
Apogee Therapeutics
APGE
NASDAQ
Watchlist
Leave a Comment
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$49.21
-0.87
-1.74%
At Close: -
$49.21
0
0.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Get Report
Comment
Apogee Therapeutics (APGE) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Apogee Therapeutics (NASDAQ:APGE) Stock
Apogee Therapeutics Stock (NASDAQ: APGE)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Sunday, July 14, 2024
XPeng & QuantumScape Are Among Top 11 Mid Cap Stocks That Performed Well Last Week (July 7-July 13): Details
Lekha Gupta
Thursday, July 11, 2024
Methode Electronics Posts Strong Sales, Joins QuantumScape, Ribbon Communications And Other Big Stocks Moving Higher On Thursday
Avi Kapoor
Wednesday, May 15, 2024
Apogee Doses First Patient In Phase 2 Atopic ...
Benzinga Newsdesk
Monday, May 13, 2024
Apogee Therapeutics Advances in Clinical Tria...
Benzinga Newsdesk
Friday, May 10, 2024
Apogee Therapeutics shares are trading higher...
Benzinga Newsdesk
B of A Securities Initiates Coverage On Apoge...
Benzinga Newsdesk
Monday, March 25, 2024
Apogee Therapeutics Has Dosed First Participa...
Benzinga Newsdesk
Thursday, March 14, 2024
Top 3 Health Care Stocks That Are Ticking Portfolio Bombs
Avi Kapoor
Friday, March 08, 2024
Reported Earlier, Apogee Therapeutics Prices ...
Benzinga Newsdesk
Wednesday, March 06, 2024
Apogee Therapeutics shares are trading higher...
Benzinga Newsdesk
Jefferies Maintains Buy on Apogee Therapeutic...
Benzinga Newsdesk
Tuesday, March 05, 2024
Apogee Therapeutics Announces Commencement Of...
Benzinga Newsdesk
Apogee Therapeutics Files For Offering Of 6M ...
Benzinga Newsdesk
Crude Oil Down 1%; Dave Shares Jump After Q4 Results
Avi Kapoor
Stifel Maintains Buy on Apogee Therapeutics, ...
Benzinga Newsdesk
Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
Guggenheim Maintains Buy on Apogee Therapeuti...
Benzinga Newsdesk
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Nasdaq Down 250 Points; ISM Services PMI Falls In February
Avi Kapoor
Why Is Atopic Dermatitis-Focused Apogee Therapeutics Stock Trading Higher On Tuesday?
Vandana Singh
NIO Reports Upbeat Earnings, Joins Dave, V2X, Riskified And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor
Dow Dips Over 100 Points; Target Posts Upbeat Earnings
Avi Kapoor
Market-Moving News for March 5th
Benzinga Newsdesk
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Apogee Therapeutics shares are trading higher...
Benzinga Newsdesk
Apogee Therapeutics 2023 Net Loss Of $(31.7)M...
Benzinga Newsdesk
Apogee Announces Interim Results from Phase 1...
Benzinga Newsdesk
Monday, March 04, 2024
Apogee To Host Conference Call And Webcast To...
Benzinga Newsdesk
Wednesday, January 03, 2024
Guggenheim Maintains Buy on Apogee Therapeuti...
Benzinga Newsdesk
Friday, December 22, 2023
Why AAR Shares Are Trading Lower By 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
Wednesday, December 20, 2023
Apogee Therapeutics shares are trading higher...
Benzinga Newsdesk
BTIG Initiates Coverage On Apogee Therapeutic...
Benzinga Newsdesk
Tuesday, September 26, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Monday, August 28, 2023
Apogee Therapeutics Q2 Net Loss Of $18.90M Do...
Benzinga Newsdesk
Tuesday, August 08, 2023
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2023
Benzinga Insights
TD Cowen Initiates Coverage On Apogee Therape...
Benzinga Newsdesk
Wedbush Initiates Coverage On Apogee Therapeu...
Benzinga Newsdesk
Stifel Initiates Coverage On Apogee Therapeut...
Benzinga Newsdesk
Jefferies Initiates Coverage On Apogee Therap...
Benzinga Newsdesk
Guggenheim Initiates Coverage On Apogee Thera...
Benzinga Newsdesk
Monday, August 07, 2023
Apogee Announces First Participants Dosed Ahe...
Benzinga Newsdesk
Friday, July 14, 2023
Apogee Therapeutics Shares Open For Trade At ...
Benzinga Newsdesk
Apogee Therapeutics IPO Indicating $22.10 On ...
Benzinga Newsdesk
Apogee Therapeutics IPO Indicating $22.10 On ...
Happy Mohamed
Thursday, July 13, 2023
Preview: Apogee Therapeutics, Inc Set To IPO Tomorrow
Benzinga Insights
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch